Modified polio vaccine extends lives in US brain cancer study
Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumors who received standard therapies, U.S. researchers said on Tuesday.
0 comments:
Post a Comment